Trial Outcomes & Findings for Fresh Food Farmacy: A Randomized Controlled Trial (NCT NCT03718832)
NCT ID: NCT03718832
Last Updated: 2025-06-12
Results Overview
Glycated hemoglobin (HbA1c) is a measure of the average share of glucose that has been in the bloodstream over the 2-3 months preceding measurement. HbA1c is measured by performing assays on samples of the participants' blood. Units are percentages; for differences between HbA1c values, units are percentage points. An HbA1c value of 6.5% is the lower threshold for type 2 diabetes. HbA1c values are rarely above 15-20%. In the context of this study (patients with type 2 diabetes), higher scores are considered a worse outcome.
COMPLETED
NA
500 participants
6 months after trial enrollment
2025-06-12
Participant Flow
Participant milestones
| Measure |
Treatment Group-Begin Now
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Analysis Sample
STARTED
|
249
|
251
|
|
Analysis Sample
COMPLETED
|
230
|
235
|
|
Analysis Sample
NOT COMPLETED
|
19
|
16
|
|
6-month HbA1c Sample
STARTED
|
230
|
235
|
|
6-month HbA1c Sample
COMPLETED
|
170
|
179
|
|
6-month HbA1c Sample
NOT COMPLETED
|
60
|
56
|
Reasons for withdrawal
| Measure |
Treatment Group-Begin Now
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Analysis Sample
Withdrawal by Subject
|
18
|
15
|
|
Analysis Sample
Legal hold on data
|
1
|
0
|
|
Analysis Sample
Participant from treated household
|
0
|
1
|
|
6-month HbA1c Sample
Lost to Follow-up
|
60
|
56
|
Baseline Characteristics
Fresh Food Farmacy: A Randomized Controlled Trial
Baseline characteristics by cohort
| Measure |
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
Total
n=465 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
54.8 years
STANDARD_DEVIATION 11.3 • n=99 Participants
|
54.4 years
STANDARD_DEVIATION 12.4 • n=107 Participants
|
54.6 years
STANDARD_DEVIATION 11.8 • n=206 Participants
|
|
Sex: Female, Male
Female
|
130 Participants
n=99 Participants
|
125 Participants
n=107 Participants
|
255 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
100 Participants
n=99 Participants
|
110 Participants
n=107 Participants
|
210 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Hispanic (any race)
|
16 Participants
n=99 Participants
|
23 Participants
n=107 Participants
|
39 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic Black
|
23 Participants
n=99 Participants
|
18 Participants
n=107 Participants
|
41 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic White
|
189 Participants
n=99 Participants
|
189 Participants
n=107 Participants
|
378 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic and other race
|
2 Participants
n=99 Participants
|
5 Participants
n=107 Participants
|
7 Participants
n=206 Participants
|
|
Region of Enrollment
United States
|
230 Participants
n=99 Participants
|
235 Participants
n=107 Participants
|
465 Participants
n=206 Participants
|
|
Prior-year healthcare use
Any inpatient admission
|
59 Participants
n=99 Participants
|
48 Participants
n=107 Participants
|
107 Participants
n=206 Participants
|
|
Prior-year healthcare use
Any emergency department visit
|
97 Participants
n=99 Participants
|
94 Participants
n=107 Participants
|
191 Participants
n=206 Participants
|
|
Clinic location
Rural
|
64 Participants
n=99 Participants
|
67 Participants
n=107 Participants
|
131 Participants
n=206 Participants
|
|
Clinic location
Urban
|
166 Participants
n=99 Participants
|
168 Participants
n=107 Participants
|
334 Participants
n=206 Participants
|
PRIMARY outcome
Timeframe: 6 months after trial enrollmentPopulation: Participants from the 465-person analysis sample who completed an HbA1c blood test between 5 and 10 months after program enrollment.
Glycated hemoglobin (HbA1c) is a measure of the average share of glucose that has been in the bloodstream over the 2-3 months preceding measurement. HbA1c is measured by performing assays on samples of the participants' blood. Units are percentages; for differences between HbA1c values, units are percentage points. An HbA1c value of 6.5% is the lower threshold for type 2 diabetes. HbA1c values are rarely above 15-20%. In the context of this study (patients with type 2 diabetes), higher scores are considered a worse outcome.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=170 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=179 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
HbA1c
|
8.781177 % of hemoglobin
Standard Deviation 1.643995
|
8.814526 % of hemoglobin
Standard Deviation 1.978937
|
SECONDARY outcome
Timeframe: 12 months after trial enrollmentGlycated hemoglobin. Units are percentages (for differences, percentage points) reflecting the average share of glucose in the bloodstream over the previous 2-3 months. An HbA1c value of 6.5% is the lower threshold for type 2 diabetes. HbA1c values are rarely above 15-20%. In the context of this study (patients with type 2 diabetes), higher scores are considered a worse outcome.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=164 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=161 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
HbA1c
|
8.735975 % of hemoglobin
Standard Deviation 1.748229
|
8.595031 % of hemoglobin
Standard Deviation 2.035983
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in the number of participants who completed blood tests between 6 and 12 months after trial enrollment.
Fasting blood glucose is a measure of blood sugar control over a short time period (the blood glucose content after an overnight fast). Units are mg/dL. To convert to mmol/L (SI), multiply by 0.0113. Lower fasting blood glucose levels indicate better health within the context of this study.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=127 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=137 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Fasting Glucose
6 months after trial enrollment
|
185.0236 mg/dL
Standard Deviation 76.36467
|
198.292 mg/dL
Standard Deviation 99.97935
|
|
Fasting Glucose
12 months after trial enrollment
|
185.4696 mg/dL
Standard Deviation 68.86821
|
172.3441 mg/dL
Standard Deviation 68.18301
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in the number of participants who had their weight recorded between 6 and 12 months after trial enrollment.
Weight in pounds. In the context of this study, higher values are considered a worse outcome. SI conversion factor: To convert pounds to kilograms, multiply by 0.4536.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=195 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=205 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Weight (lb)
6 months after trial enrollment
|
230.8205 pounds (lb)
Standard Deviation 60.13527
|
238.9561 pounds (lb)
Standard Deviation 66.3286
|
|
Weight (lb)
12 months after trial enrollment
|
227.9171 pounds (lb)
Standard Deviation 58.1217
|
237.5989 pounds (lb)
Standard Deviation 63.47953
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in the number of participants whose weight was recorded between 6 and 12 months after trial enrollment.
Body Mass Index (BMI) in kg/m\^2. BMI is computed using weight (lb) and height (in). The CDC's healthy reference range for BMI among adults aged 20 and older is 18.5 to 24.9. BMI values greater than or equal to 30.0 indicate obesity. In the context of this study, higher BMI is considered a worse outcome.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=195 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=205 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Body Mass Index
6 months after trial enrollment
|
36.77117 kg/m^2
Standard Deviation 8.615884
|
37.6461 kg/m^2
Standard Deviation 10.06821
|
|
Body Mass Index
12 months after trial enrollment
|
36.20175 kg/m^2
Standard Deviation 8.299285
|
37.65195 kg/m^2
Standard Deviation 9.895644
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in the number of participants who completed blood tests including cholesterol measurements between 6 and 12 months after trial enrollment.
Total cholesterol in mg/dL. The CDC recommends total cholesterol levels around 150 mg/dL and classifies levels of 200 mg/dL and above as unhealthy (hyperlipidemia). In the context of this study, higher total cholesterol indicates a worse outcome. SI conversion factor: To convert from mg/dL to mmol/L, multiply by 0.0259.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=149 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=161 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Total Cholesterol
6 months after trial enrollment
|
170.3087 mg/dL
Standard Deviation 55.49542
|
160.5404 mg/dL
Standard Deviation 48.39021
|
|
Total Cholesterol
12 months after trial enrollment
|
164.8345 mg/dL
Standard Deviation 50.04346
|
165.3806 mg/dL
Standard Deviation 56.96481
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in the number of participants who completed blood tests including cholesterol measurements between 6 and 12 months after trial enrollment.
Low-density lipoprotein (LDL) cholesterol, measured in mg/dL. The CDC recommends LDL levels of 100 mg/dL or below. In the context of this study, higher levels of LDL indicate a worse outcome. SI conversion factor: To convert from mg/dL to mmol/L, multiply by 0.0259.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=151 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=158 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
LDL Cholesterol
6 months after trial enrollment
|
93.54835 mg/dL
Standard Deviation 44.67019
|
85.19621 mg/dL
Standard Deviation 36.72769
|
|
LDL Cholesterol
12 months after trial enrollment
|
87.36268 mg/dL
Standard Deviation 36.73616
|
84.72519 mg/dL
Standard Deviation 36.62367
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in the number of participants who completed blood tests including cholesterol measurements between 6 and 12 months after trial enrollment.
High-density lipoprotein (HDL) cholesterol, measured in mg/dL. The CDC recommends HDL levels of at least 40 mg/dL in men and 50 mg/dL in women. In the context of this study, higher levels of HDL indicate a better outcome. SI conversion factor: To convert mg/dL to mmol/L, multiply by 0.0259.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=149 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=161 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
HDL Cholesterol
6 months after trial enrollment
|
41.27718 mg/dL
Standard Deviation 12.98269
|
41.8323 mg/dL
Standard Deviation 12.08006
|
|
HDL Cholesterol
12 months after trial enrollment
|
42.34722 mg/dL
Standard Deviation 12.73743
|
43.73333 mg/dL
Standard Deviation 17.07761
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in the number of participants who completed blood tests including cholesterol measurements between 6 and 12 months after trial enrollment.
Triglycerides, measured in mg/dL. The CDC recommends levels of triglycerides below 150 mg/dL. In the context of this study, higher levels of triglycerides indicate worse outcomes. SI conversion factor: To convert mg/dL to mmol/L, multiply by 0.0113.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=149 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=162 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Triglycerides
6 months after trial enrollment
|
223.5705 mg/dL
Standard Deviation 155.5674
|
201.0123 mg/dL
Standard Deviation 157.1144
|
|
Triglycerides
12 months after trial enrollment
|
212.7762 mg/dL
Standard Deviation 153.4214
|
224.1288 mg/dL
Standard Deviation 268.9378
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in the number of participants who had their blood pressure recorded between 6 and 12 months after trial enrollment.
Systolic blood pressure, measured in mm Hg. The CDC identifies normal healthy systolic blood pressure as below 120 mm Hg. The American College of Cardiology identifies 120 to 129 mm Hg as elevated blood pressure and 130 mm Hg and higher as hypertensive. Higher systolic blood pressure levels indicate worse outcomes.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=186 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=192 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Systolic Blood Pressure
6 months after trial enrollment
|
128.3118 mm Hg
Standard Deviation 19.06545
|
130.1823 mm Hg
Standard Deviation 20.29064
|
|
Systolic Blood Pressure
12 months after trial enrollment
|
126.0235 mm Hg
Standard Deviation 17.24071
|
129.7956 mm Hg
Standard Deviation 18.45165
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in the number of participants who had their blood pressure recorded between 6 and 12 months after trial enrollment.
Diastolic blood pressure, measured in mm Hg. The American College of Cardiology identifies normal diastolic blood pressure as below 80 mm Hg and elevated/hypertensive diastolic blood pressure as 80 mm Hg or above. Higher levels of diastolic blood pressure indicate worse outcomes.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=186 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=192 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Diastolic Blood Pressure
6 months after trial enrollment
|
74.2043 mm Hg
Standard Deviation 10.71504
|
74.76041 mm Hg
Standard Deviation 10.40413
|
|
Diastolic Blood Pressure
12 months after trial enrollment
|
74.48235 mm Hg
Standard Deviation 9.271847
|
73.98343 mm Hg
Standard Deviation 10.46395
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.
Patient-reported measure of diet improvement: Number of times in the last 7 days when the patient ate fruit.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=163 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=170 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Times Eating Fruit in the Past 7 Days
6 months after trial enrollment
|
5.564417 # times
Standard Deviation 3.344494
|
5.241177 # times
Standard Deviation 3.397799
|
|
Times Eating Fruit in the Past 7 Days
12 months after trial enrollment
|
5.097222 # times
Standard Deviation 2.377986
|
5.79562 # times
Standard Deviation 3.343428
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.
Patient-reported measure of diet improvement: Number of times in the last 7 days when the patient ate dark green vegetables.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=163 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=170 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Times Eating Dark Green Vegetables in the Past 7 Days
6 months after trial enrollment
|
6.288343 # times
Standard Deviation 20.69643
|
4.011765 # times
Standard Deviation 2.9007
|
|
Times Eating Dark Green Vegetables in the Past 7 Days
12 months after trial enrollment
|
4.202797 # times
Standard Deviation 2.378186
|
5.782609 # times
Standard Deviation 8.36899
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.
Patient-reported measure of diet improvement: Number of times in the last 7 days when the patient drank sweetened beverages.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=162 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=167 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Times Drinking Sweetened Beverages in the Past 7 Days
6 months after trial enrollment
|
2.777778 # times
Standard Deviation 3.449728
|
3.407186 # times
Standard Deviation 4.495186
|
|
Times Drinking Sweetened Beverages in the Past 7 Days
12 months after trial enrollment
|
2.377622 # times
Standard Deviation 3.116978
|
2.550725 # times
Standard Deviation 3.60266
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.
Patient-reported measure of diet improvement: Number of times in the last 7 days when the patient ate fast food, takeout, or at a restaurant.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=164 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=171 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Times Eating Out in the Past 7 Days
6 months after trial enrollment
|
4.5 # times
Standard Deviation 3.948285
|
4.017544 # times
Standard Deviation 3.78771
|
|
Times Eating Out in the Past 7 Days
12 months after trial enrollment
|
4.402778 # times
Standard Deviation 3.956617
|
4.413043 # times
Standard Deviation 3.927682
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.
Patient-reported measure of diet improvement: Survey question: "Do you believe your diet has improved compared to one year ago?".
Outcome measures
| Measure |
Treatment Group-Begin Now
n=164 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=171 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Participants Answering "Yes" for Diet Improvement Compared to One Year Ago
6 months after trial enrollment
|
153 Participants
|
132 Participants
|
|
Participants Answering "Yes" for Diet Improvement Compared to One Year Ago
12 months after trial enrollment
|
137 Participants
|
129 Participants
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.
The proportion of questions testing patients' knowledge of how different factors contribute to blood sugar answered correctly.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=160 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=170 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Mean Proportion of Diabetes Knowledge Questions Answered Correctly
6 months after trial enrollment
|
0.8267857 proportion of questions
Standard Deviation 0.1489169
|
0.7756302 proportion of questions
Standard Deviation 0.1472909
|
|
Mean Proportion of Diabetes Knowledge Questions Answered Correctly
12 months after trial enrollment
|
0.8271728 proportion of questions
Standard Deviation 0.1416987
|
0.8133472 proportion of questions
Standard Deviation 0.1444886
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.
Survey-based index score for patient-reported positive engagement outcomes. Scores range from 0 to 1. Scores are standardized so that the control group always has a mean score of 0 and standard deviation of 1. Higher scores reflect better outcomes---here, better engagement with the program. Scores composite results from multiple survey questions while adjusting for covariance between questions.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=164 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=171 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Engagement Index Score
6 months after trial enrollment
|
0.4018523 score on a scale
Standard Deviation 0.8282961
|
0 score on a scale
Standard Deviation 1
|
|
Engagement Index Score
12 months after trial enrollment
|
0.000623 score on a scale
Standard Deviation 0.8280342
|
0 score on a scale
Standard Deviation 1
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed may differ due to differences in the number of participants who remained continuously enrolled in the health plan between 6 and 12 months after trial enrollment.
Healthcare utilization: Number of outpatient claims among continuously enrolled/insured subjects during the relevant time frame after trial enrollment.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Number of Outpatient Visits Claimed by Insurance
6 months after trial enrollment
|
5.765217 Number of claims
Standard Deviation 4.884394
|
4.86383 Number of claims
Standard Deviation 4.628804
|
|
Number of Outpatient Visits Claimed by Insurance
12 months after trial enrollment
|
10.1 Number of claims
Standard Deviation 8.088674
|
10.07234 Number of claims
Standard Deviation 8.314793
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed may differ due to differences in the number of participants who remained continuously enrolled in the health plan between 6 and 12 months after trial enrollment.
Healthcare utilization: Number of inpatient and emergency department claims among continuously enrolled/insured subjects during the relevant time frame after enrollment.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Number of Inpatient and Emergency Department Visits Claimed by Insurance
6 months after trial enrollment
|
0.6869565 Number of claims
Standard Deviation 1.363051
|
0.7914894 Number of claims
Standard Deviation 1.680434
|
|
Number of Inpatient and Emergency Department Visits Claimed by Insurance
12 months after trial enrollment
|
1.221739 Number of claims
Standard Deviation 2.116365
|
1.497872 Number of claims
Standard Deviation 3.350436
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed may differ due to differences in the number of participants who remained continuously enrolled in the health plan between 6 and 12 months after trial enrollment.
The number of subjects who were continuously enrolled/insured who had any outpatient claims during the relevant time frame after trial enrollment. For statistical analyses, coefficients and errors represent proportions of participants, relative to the size of the group/treatment arm.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Proportion of Participants Filing Outpatient Insurance Claims With Insurance
6 months after trial enrollment
|
215 Participants
|
207 Participants
|
|
Proportion of Participants Filing Outpatient Insurance Claims With Insurance
12 months after trial enrollment
|
221 Participants
|
224 Participants
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed may differ due to differences in the number of participants who remained continuously enrolled in the health plan between 6 and 12 months after trial enrollment.
The number of subjects who were continuously enrolled/insured who had any inpatient or emergency department claims during the relevant time frame after trial enrollment. For statistical analyses, coefficients and errors represent proportions of participants, relative to the size of the group/treatment arm.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Proportion of Participants Filing Inpatient or Emergency Department Claims With Insurance
6 months after trial enrollment
|
70 Participants
|
84 Participants
|
|
Proportion of Participants Filing Inpatient or Emergency Department Claims With Insurance
12 months after trial enrollment
|
96 Participants
|
110 Participants
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed may differ due to differences in the number of participants who remained continuously enrolled in the health plan between 6 and 12 months after trial enrollment.
Healthcare utilization: Total value (USD) of inpatient and emergency department payments among continuously enrolled/insured subjects during the relevant time frame after enrollment.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=105 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=96 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Inpatient and Emergency Department Payments
6 months after trial enrollment
|
2175.39 USD
Standard Deviation 6176.236
|
2161.593 USD
Standard Deviation 5284.944
|
|
Inpatient and Emergency Department Payments
12 months after trial enrollment
|
3284.667 USD
Standard Deviation 7850.193
|
4545.119 USD
Standard Deviation 9951.439
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentPopulation: Number of participants analyzed may differ due to differences in the number of participants who remained continuously enrolled in the health plan between 6 and 12 months after trial enrollment.
Healthcare utilization: Value (USD) of outpatient payments among continuously enrolled/insured subjects during the relevant time frame after enrollment.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=105 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=96 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Outpatient Payments
6 months after trial enrollment
|
3313.627 USD
Standard Deviation 6553.01
|
2023.022 USD
Standard Deviation 3492.728
|
|
Outpatient Payments
12 months after trial enrollment
|
5327.305 USD
Standard Deviation 7561.854
|
4117.954 USD
Standard Deviation 5205.939
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentThe number of times an individual participant completed a medical appointment with a dietician in the relevant time frame, based on electronic health records.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Number of Visits to a Dietician
6 months after trial enrollment
|
2.656522 number of visits
Standard Deviation 1.745694
|
0.6212766 number of visits
Standard Deviation 1.263041
|
|
Number of Visits to a Dietician
12 months after trial enrollment
|
4.53913 number of visits
Standard Deviation 3.029079
|
2.919149 number of visits
Standard Deviation 2.701269
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentThe number of times an individual participant completed a Diabetes Self-Management Training (DSMT) in the relevant time frame, based on electronic health records.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Number of Diabetes Self-Management Trainings Completed
6 months after trial enrollment
|
2.243478 number of trainings
Standard Deviation 1.439258
|
0.3617021 number of trainings
Standard Deviation 0.7168763
|
|
Number of Diabetes Self-Management Trainings Completed
12 months after trial enrollment
|
3.791304 number of trainings
Standard Deviation 2.498893
|
2.140425 number of trainings
Standard Deviation 1.888297
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentThe number of times an individual participant completed a medical appointment with an endocrinologist in the relevant time frame, based on electronic health records.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Number of Visits to an Endocrinologist
6 months after trial enrollment
|
0.5913044 number of appointments
Standard Deviation 0.8605437
|
0.4808511 number of appointments
Standard Deviation 0.7970668
|
|
Number of Visits to an Endocrinologist
12 months after trial enrollment
|
1.095652 number of appointments
Standard Deviation 1.468588
|
0.8893617 number of appointments
Standard Deviation 1.302731
|
SECONDARY outcome
Timeframe: 6 and 12 months after trial enrollmentThe number of times an individual participant completed a medical appointment regarding weight loss or weight management in the relevant time frame, based on electronic health records.
Outcome measures
| Measure |
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total).
Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
|
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
|
|---|---|---|
|
Number of Weight Loss and Weight Management Appointments Completed
6 months after trial enrollment
|
0.0521739 number of appointments
Standard Error 0.3457409
|
0.1106383 number of appointments
Standard Error 0.5193825
|
|
Number of Weight Loss and Weight Management Appointments Completed
12 months after trial enrollment
|
0.0521739 number of appointments
Standard Error 0.3457409
|
0.2212766 number of appointments
Standard Error 0.9707113
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsHealthy behaviors observed in electronic health record, including preventive care and appointments kept
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsHealthy behaviors observed in paid claims using Healthcare Effectiveness Data and Information Set (HEDIS) measures. These measures were not collected for this study.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsHbA1c available in EHR records
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsWeight in pounds as available in EHR records
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsBMI in kg/m\^2 in pounds as available in EHR records
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsCholesterol as available in EHR records
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsBlood pressure as available in EHR records
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsTriglycerides as available in EHR records
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsFasting glucose as available in EHR records
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsInpatient utilization for household members as available in EHR records
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsOutpatient utilization for household members as available in EHR records
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsInpatient utilization for household members as available in paid claims
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsOutpatient utilization for household members as available in paid claims
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsSeparate results by tercile of baseline HbA1c
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsHeterogeneity analysis by site of the clinic
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 months and 12 monthsHeterogeneity analysis by causal trees using the baseline characteristics to explore heterogeneity, sample size permitting.
Outcome measures
Outcome data not reported
Adverse Events
Treatment Group-Begin Now
Control Group-Begin Later
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place